NVONOVO NORDISK A S

NYSE novonordisk.com


$ 131.87 $ -1.15 (-0.86 %)    

Friday, 17-May-2024 15:59:55 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 131.89
$ 131.91
$ 131.85 x 200
$ 0.00 x 0
$ 130.92 - $ 132.02
$ 74.66 - $ 137.29
2,585,900
na
594,824
$ 0.65
$ 0.00
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 no-wegovy-shortage-in-denmark-amid-high-demand-novo-nordisk-confirms

Novo Nordisk confirms there is no anticipated shortage of Wegovy in Denmark, despite prior warnings from the Danish Medicines A...

 eli-lilly-strikes-deal-to-combat-counterfeit-diabetes-and-weight-loss-drugs-mounjaro-and-zepbound

Eli Lilly has settled with Totality Medispa over counterfeit Mounjaro and Zepbound sales. The spa will pay damages and cease us...

Core News & Articles

https://www.wsj.com/livecoverage/stock-market-today-dow-jones-05-14-2024/card/lilly-settles-with-spa-selling-mounjaro-zepbound-...

 novo-nordisks-wegovy-delivers-long-term-study-shows-sustained-weight-loss-as-drugmaker-tries-to-woo-insurers-and-governments

The data could potentially bolster Novo's case for Wegovy as it attempts to convince insurers and governments to cover the...

 novo-nordisks-hemophilia-candidate-can-prevent-bleeding-episodes-effectively-regardless-of-dosing-frequency

Novo Nordisk's Phase 3a trial demonstrates a significant reduction in bleeding episodes with Mim8 treatment for hemophilia ...

 novo-nordisk-announces-headline-results-from-the-frontier-2-trial-achieved-its-co-primary-endpoints-by-demonstrating-a-reduction-of-treated-bleeding-episodes-with-both-once-weekly-and-once-monthly-mim8-versus-no-prophylaxis-treatment-and-prior-coagulation-factor-prophylaxis-treatment

https://ml-eu.globenewswire.com/Resource/Download/be52a7ec-2630-49c0-b374-88ae71352c87

 ozempic-ftw-elon-musk-touts-novo-nordisks-blockbuster-drug-as-solution-to-childhood-obesity-problem

This is not the first time the tech mogul has seemingly backed the blockbuster drug. Last year, Musk claimed that Ozempic was a...

 wage-growth-slows--stock-market-celebrates-five-real-reasons-apple-is-running-up

To gain an edge, this is what you need to know today.

 job-market-cools-in-april-payrolls-miss-forecasts-wages-rise-less-than-expected-updated

U.S. labor market misses April expectations, signaling slower economic growth and potential interest rate cuts. Stocks rise, Tr...

 weight-loss-competition-heats-up-in-britain-online-pharmacies-slash-prices-for-wegovy-and-mounjaro

Reduced prices on Wegovy and Mounjaro at British pharmacies amid growing competition. Simple Online Pharmacy slashes Mounjaro s...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION